Jim Mellon
British entrepreneur, author and philanthropist with interests across a number of industries
Jim began his investment career in Asia and then moved to the US and worked for two fund management companies, GT Management and Thornton & Co. During this time he gained valuable insights into the companies and economies which would drive global growth over the following decades. He established his own business in 1991, which today persists as Charlemagne Capital and was recently acquired by Fiera Capital. He still controls Regent Pacific Group, a Hong Kong-listed company.
Through his private investment company, the Burnbrae Group, he has substantial real estate investments in Germany and in the Isle of Man, as well as shareholdings in private and public companies in sectors such as banking, commodities, leisure and healthcare.
Jim’s investment philosophy, which has led him to be recognised as one of the most successful investors of his generation, is underpinned by his ability to identify so-called “money-fountains” – market trends which will lead to step changes and the resulting investment opportunities.
Visit website: https://www.juvenescence-book.com/about-the-authors/
See also: 
Juvenescence
- Developing therapies against different aging related diseases.
Details last updated 24-Jun-2019
Jim Mellon is also referenced in the following:
Investing in the Future of Longevity – the Ketone Chapter
10-May-2022
Juvenescence webinar about the latest research and developments on future of longevity investment
Longevity Med Summit
04-May-2023 to 05-May-2023
Annual gathering of the entire longevity ecosystem to tackle the aging problem
Longevity Summit Dublin 2022
18-Sep-2022 to 20-Sep-2022
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Transvision Madrid 2021
08-Oct-2021 to 10-Oct-2021
World congress discussing on futurist concepts like longevity extension, artificial intelligence, human enhancement and other technologies with first humanoid robot speaker, Sophia, organized by HumanityPlus.
Jim Mellon Creations
Juvenescence: Investing in the Age of Longevity
The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies
Jim Mellon News
Summary of Jim Mellon presentation at Longevity Med Summit
Live Forever Club - 19-May-2023
Urges individuals with resources and a desire to contribute positively to humanity to invest in the longevity industry
Read more...SIRT6 variant plays a major role in preventing the aging process
Longevity Technology - 17-Aug-2021
Novel gene therapies to prevent the accelerated aging process
Read more...FDA approved LyGenesis' phase 2a trials on liver failure patients
Longevity Technology - 30-Dec-2020
Raised $11M funding which goes into trials and developing functional organs
Read more...Donations being triple matched for SENS end-of-year fundraiser
SENS Research Foundation - 01-Dec-2020
I've just donated to help #UnlockLongevity - these are the experts and they need funding!
Read more...Big investors join First Longevity funding round
Longevity Technology - 16-Oct-2020
Key investors raise funding to support longevity sector
Read more...Jim Mellon plans to take his longevity company Juvenescence public
CNBC - 29-Sep-2020
The company with $170 million private funding has invested in various life extension therapies
Read more...Orion College ageing research receives 1 million UK pounds from Jim Mellon
Lifespan.io (LEAF) - 18-May-2020
He believes in the importance of boosting immunoresilience among elderly
Read more...Say hello to the life-extensionists
Guardian - 23-Jun-2019
A fair summary of who's who in life extension from a journalist who clearly isn't convinced :)
Read more...UK biotech company focused on developing anti-ageing therapies
PMLiVE - 12-Jun-2018
LyGenesis seeks to use a patient’s own lymph nodes as bioreactors to grow functioning ectopic organs
Read more...Interview with Juvenescence author Jim Mellon
Medium - 17-May-2018
Juvenescence Ltd is making investments in the future of rejuvenation and life extension technology
Read more...Silicon Valley and rich people invest to slow down ageing and live longer
This Is Money - 17-Mar-2018
All the money in the world to fight ageing and death
Read more...AI-powered application to assess visual aging biomarkers in lab animals
Lifespan.io (LEAF) - 29-Aug-2017
Lifespan.io is launching a crowdfunding campaign to support MouseAGE. Software will assess visua...
Read more...British billionaire gambles on an anti-aging upstart
Endpoints News - 26-Jul-2017
We are at an inflection point for the treatment of aging. We can generate molecules with specifi...
Read more...Billionaire Jim Mellon invests in anti-ageing research firm
pharmaphorum - 11-Apr-2017
Insilico Medicine applying big data analytics to extend healthy longevity. pursuing internal dru...
Read more...
